Press Releases

NEW YORK, Oct. 22, 2019 /PRNewswire/ -- The Edmond J. Safra Fellowship in Movement Disorders has selected five neurology physicians for the Class of 2022, the program's fifth class, from top neurology programs across the world. This summer, these individuals will begin two years of training to become movement disorder clinician-researchers — experts in treatin

WELLESLEY, Mass., Oct. 22, 2019 /PRNewswire/ -- 4G Clinical today announced its recognition as the Bio Supply Management Alliance (BSMA)

MONTREAL, Oct. 22, 2019 /PRNewswire/ - Optina Diagnostics, a world leader in retinal imaging technology and AI with a vision to change mindsets when it comes to brain health and Dr. Jean-Claude Tardif's research group from the Montreal Heart Institute, have partnered with the aim to develop a new biomarker for atherosclerosis diagnosis.

DURHAM, N.C., Oct. 22, 2019 /PRNewswire/ -- Vast Therapeutics, Inc., a subsidiary of KNOW Bio, LLC, announces that BIOC11 eradicated 99% of the Nontuberculous Mycobacteria

PLAINSBORO, N.J., Oct. 22, 2019 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp® (insulin aspart injection) 100 u/mL to include use in insulin infusion pumps for the improvement of glycemic control in adults with type 1 or type 2 diabetes.1 Fiasp®, a ra

SANTA CLARA, Calif., Oct. 22, 2019 /PRNewswire/ -- OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced from

MOUNT ROYAL, N.J., Oct. 22, 2019 /PRNewswire/ -- A recent study published in the New England Journal of Medicine supports

SAN DIEGO, Oct. 22, 2019 /PRNewswire/ -- Neurelis, Inc., a privately held specialty pharmaceutical company focused on licensing, developing and commercializing product candidates for epilepsy and the broader central nervous system (CNS) market, announced today that the company will have three poster presentations at the 48th annual meeting of the Child Neurolog

WINDSOR, Conn., Oct. 22, 2019 /PRNewswire/ -- 

CAMBRIDGE, Mass., Oct. 22, 2019 /PRNewswire/ -- Children's National Research Institute (CNRI), the research arm of the nation's No. 6 ranked children's hospital is rolling out the TriNetX platform to investigators at Children's National Hospital and taking the lead in establishing a research collaborative among pediatric hospitals within TriNetX's global health research